JP2019501116A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501116A5 JP2019501116A5 JP2018522990A JP2018522990A JP2019501116A5 JP 2019501116 A5 JP2019501116 A5 JP 2019501116A5 JP 2018522990 A JP2018522990 A JP 2018522990A JP 2018522990 A JP2018522990 A JP 2018522990A JP 2019501116 A5 JP2019501116 A5 JP 2019501116A5
- Authority
- JP
- Japan
- Prior art keywords
- wetting
- gibinostat
- aqueous vehicle
- hydration process
- intimate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 239000008135 aqueous vehicle Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102015000068150 | 2015-11-03 | ||
| ITUB2015A005193A ITUB20155193A1 (it) | 2015-11-03 | 2015-11-03 | Sospensioni orali di Givinostat fisicamente e chimicamente stabili |
| PCT/IB2016/056496 WO2017077436A1 (en) | 2015-11-03 | 2016-10-28 | Physically and chemically stable oral suspensions of givinostat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501116A JP2019501116A (ja) | 2019-01-17 |
| JP2019501116A5 true JP2019501116A5 (enExample) | 2019-06-27 |
| JP6800970B2 JP6800970B2 (ja) | 2020-12-16 |
Family
ID=55410062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522990A Active JP6800970B2 (ja) | 2015-11-03 | 2016-10-28 | 物理的および化学的に安定なギビノスタットの経口懸濁液 |
Country Status (33)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7373991B2 (ja) | 2016-07-15 | 2023-11-06 | ビラクタ セラピューティクス，インク． | 免疫療法で使用するためのヒストン脱アセチル化酵素阻害剤 |
| IT201900003281A1 (it) * | 2019-03-06 | 2020-09-06 | Chemi Spa | Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza |
| SG11202113215UA (en) | 2019-05-31 | 2021-12-30 | Viracta Subsidiary Inc | Methods of treating virally associated cancers with histone deacetylase inhibitors |
| WO2022088037A1 (zh) * | 2020-10-30 | 2022-05-05 | 中国科学院深圳先进技术研究院 | Sirtinol在制备预防和治疗冠状病毒的药物中的应用 |
| CN114306311A (zh) * | 2022-01-14 | 2022-04-12 | 同济大学 | 组蛋白去乙酰化酶抑制剂在制备治疗心脏病的药物中的应用 |
| CN116173003A (zh) * | 2023-02-24 | 2023-05-30 | 山西医科大学 | 药物吉维司他在治疗阿尔茨海默病中的用途 |
| WO2026052723A1 (en) | 2024-09-05 | 2026-03-12 | Italfarmaco S.P.A. | Givinostat hydrochloride monohydrate for use in treating muscular dystrophy |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4169150A (en) * | 1975-11-12 | 1979-09-25 | Teijin Limited | Benzodiazepine derivatives and pharmaceutical compositions containing said derivatives |
| DE3902079A1 (de) * | 1988-04-15 | 1989-10-26 | Bayer Ag | I.m. injektionsformen von gyrase-inhibitoren |
| US5369108A (en) | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| IT1283637B1 (it) | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| US6888027B2 (en) | 2000-09-29 | 2005-05-03 | Topotarget Uk Limited | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| US6897220B2 (en) | 2001-09-14 | 2005-05-24 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| MXPA04006165A (es) * | 2001-12-20 | 2004-11-01 | Pharmacia Corp | Suspension farmaceutica para administracion oral. |
| MXPA04007775A (es) | 2002-03-13 | 2004-10-15 | Janssen Pharmaceutica Nv | Derivados de sulfonilo como novedosos inhibidores de la histona desacetilasa. |
| ITMI20030063A1 (it) | 2003-01-17 | 2004-07-18 | Italfarmaco Spa | Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico. |
| US7244751B2 (en) | 2003-02-14 | 2007-07-17 | Shenzhen Chipscreen Biosciences Ltd. | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| HRP20090487T1 (hr) | 2003-04-07 | 2009-12-31 | Pharmacyclics | Hidroksamati kao terapeutski agensi |
| CA2535350A1 (en) | 2003-08-20 | 2005-03-03 | Axys Pharmaceuticals, Inc. | Acetylene derivatives as inhibitors of histone deacetylase |
| ITMI20041347A1 (it) | 2004-07-05 | 2004-10-05 | Italfarmaco Spa | Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria |
| EP1781639B1 (en) | 2004-07-28 | 2012-01-25 | Janssen Pharmaceutica NV | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| WO2006018814A2 (en) * | 2004-08-16 | 2006-02-23 | Ranbaxy Laboratories Limited | Oral liquid suspensions of metaxalone |
| CA2645205C (en) * | 2006-05-19 | 2012-12-04 | Norbrook Laboratories Limited | Stable aqueous suspension having palatable taste |
| CA2662937A1 (en) | 2006-09-11 | 2008-03-20 | Curis, Inc. | Multi-functional small molecules as anti-proliferative agents |
| US8263652B2 (en) * | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| AU2010313290A1 (en) * | 2009-10-30 | 2012-05-17 | Janssen Pharmaceutica Nv | Dosing regimen associated with long-acting injectable paliperidone esters |
| IT1397912B1 (it) * | 2010-01-28 | 2013-02-04 | Chemi Spa | Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato. |
| US20110245154A1 (en) * | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
| TW201245115A (en) * | 2011-01-24 | 2012-11-16 | Chdi Foundation Inc | Histone deacetylase inhibitors and compositions and methods of use thereof |
| AU2012368818B2 (en) * | 2012-02-03 | 2017-11-16 | Italfarmaco S.P.A. | Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy |
| AU2014248562B2 (en) * | 2013-03-12 | 2019-01-03 | Synedgen, Inc. | Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar |
| EP2968233A4 (en) | 2013-03-14 | 2016-08-03 | Chdi Foundation Inc | HISTON DEACETYLASE HEMMER AND COMPOSITIONS AND METHOD FOR USE THEREOF |
| WO2015086738A2 (en) | 2013-12-11 | 2015-06-18 | Bionor Immuno As | Hiv vaccine |
-
2015
- 2015-11-03 IT ITUB2015A005193A patent/ITUB20155193A1/it unknown
-
2016
- 2016-10-20 TW TW105133874A patent/TWI727983B/zh active
- 2016-10-28 RU RU2018120170A patent/RU2721396C2/ru active
- 2016-10-28 HR HRP20210747TT patent/HRP20210747T1/hr unknown
- 2016-10-28 HU HUE16805507A patent/HUE054123T2/hu unknown
- 2016-10-28 ES ES16805507T patent/ES2870201T3/es active Active
- 2016-10-28 KR KR1020187014706A patent/KR102603894B1/ko active Active
- 2016-10-28 MX MX2018004505A patent/MX380361B/es unknown
- 2016-10-28 LT LTEP16805507.7T patent/LT3370697T/lt unknown
- 2016-10-28 CN CN201680062179.0A patent/CN108366956B/zh active Active
- 2016-10-28 SI SI201631132T patent/SI3370697T1/sl unknown
- 2016-10-28 SM SM20210161T patent/SMT202100161T1/it unknown
- 2016-10-28 BR BR122024001653-2A patent/BR122024001653A2/pt not_active Application Discontinuation
- 2016-10-28 NZ NZ741467A patent/NZ741467A/en unknown
- 2016-10-28 WO PCT/IB2016/056496 patent/WO2017077436A1/en not_active Ceased
- 2016-10-28 PL PL16805507T patent/PL3370697T3/pl unknown
- 2016-10-28 DK DK16805507.7T patent/DK3370697T3/da active
- 2016-10-28 AU AU2016349169A patent/AU2016349169B2/en active Active
- 2016-10-28 EP EP16805507.7A patent/EP3370697B1/en active Active
- 2016-10-28 RS RS20210421A patent/RS61694B1/sr unknown
- 2016-10-28 CN CN202110722868.2A patent/CN113368044B/zh active Active
- 2016-10-28 CA CA3002755A patent/CA3002755C/en active Active
- 2016-10-28 PE PE2018000576A patent/PE20181369A1/es unknown
- 2016-10-28 JP JP2018522990A patent/JP6800970B2/ja active Active
- 2016-10-28 US US15/770,443 patent/US10688047B2/en active Active
- 2016-10-28 PT PT168055077T patent/PT3370697T/pt unknown
- 2016-11-02 AR ARP160103344A patent/AR106559A1/es not_active Application Discontinuation
-
2018
- 2018-04-10 IL IL258608A patent/IL258608B/en unknown
- 2018-04-13 CO CONC2018/0003971A patent/CO2018003971A2/es unknown
- 2018-04-30 CL CL2018001151A patent/CL2018001151A1/es unknown
-
2021
- 2021-05-07 CY CY20211100388T patent/CY1124092T1/el unknown
-
2025
- 2025-12-02 LT LTPA2025540C patent/LTPA2025540I1/lt unknown
- 2025-12-04 FR FR25C1051C patent/FR25C1051I1/fr active Active
- 2025-12-05 FI FIC20250035C patent/FIC20250035I1/fi unknown
- 2025-12-05 HU HUS2500049C patent/HUS2500049I1/hu unknown
- 2025-12-05 NO NO2025053C patent/NO2025053I1/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501116A5 (enExample) | ||
| Bercea et al. | Temperature responsive gels based on Pluronic F127 and poly (vinyl alcohol) | |
| CN103415536B (zh) | 具有改进的分散性能的水溶性聚合物粉末配制物 | |
| JP2009526026A5 (enExample) | ||
| WO2009022899A1 (es) | Gel conteniendo pirfenidona | |
| RU2014103279A (ru) | Самоочищающаяся антисмоговая противоплесневая фотокаталитическая порошкообразная водоразбавляемая краска | |
| JP2021502365A5 (enExample) | ||
| CN104001205B (zh) | 一种流体敷料及其制备方法 | |
| CN105463482A (zh) | 一种铝材表面除灰剂及其制备方法和进行表面除灰的方法 | |
| JP2016539910A5 (enExample) | ||
| CN104902873A (zh) | 溶解性差的活性成分的薄膜剂形式的口服和/或含服组合物、其制备方法以及其用途 | |
| JP2015162299A5 (enExample) | ||
| BR112017016657A2 (pt) | composições de sulfossuccinato de dialquila, método de feitura, e método de uso | |
| JP6110405B2 (ja) | 水溶性ポリマーを分散させる非水性方法 | |
| CN103724709A (zh) | 一种氧化普鲁兰多糖-丝胶复合物改性天然乳胶的方法 | |
| JP5940204B1 (ja) | 塗膜剥離剤 | |
| JP2003525895A5 (enExample) | ||
| JPH0439441B2 (enExample) | ||
| TWI874939B (zh) | 泡泡果凍膠體結構 | |
| JP2016520193A5 (enExample) | ||
| CN111246737B (zh) | 用于农业应用的溶剂和农药调配物 | |
| JP2005501160A5 (enExample) | ||
| JP2016537473A5 (enExample) | ||
| JP2017172220A (ja) | セメント打継ぎ用プライマーシート | |
| WO2016011596A1 (zh) | 一种高稳定性、可拍打泡泡水及其制备方法 |